secwatch / observer
8-K filed November 1, 2024, 7:59 PM ET ticker ADGM CIK 0002006986
other material confidence high sentiment negative materiality 0.85

Adagio Medical Holdings, Inc. (ADGM): auditor change — Adagio Medical announces restatement of FY2023, Q1 and Q2 2024 financials; material weakness identified

Adagio Medical Holdings, Inc.

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Adagio Medical Holdings, Inc. reported that prior financial statements should not be relied upon.

Action
non reliance
Auditor
WithumSmith+Brown, PC
Exact text from the filing
024 and 2023, which were reported in an amendment to the Business Combination Super 8-K on Form 8-K/A filed with the SEC on August 14, 2024 (the periods referenced in clause (i), (ii), and (iii), the “Relevant Periods”) should no longer be relied upon with respect to the error described below and should be restated. In addition, any earnings releases or other communications relating to the Relevant Periods should no longer be relied upon with respect to the error described below. ​ As the Company previously reported on the Business Combination Super 8-K, on July 31, 2024 (the “Closing Date”), the Company consummated a business combination pursuant to the terms of the Business Combination Ag
View on SEC.gov

18 auditor changes filed in the last 30 days. Browse all auditor changes →

Adagio Medical Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001558370-24-014144
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.